Irwin Simon, CEO of Canada-based cannabis company Tilray (NASDAQ:TLRY), said Thursday on CNBC that the company intends to drive growth by building its medical business and potential M&A. The M&A approach to growth, Simon noted, can fast-track the process because it allows Tilray to skip the hassles of building a bus
Full Story >>